Generic placeholder image

New Emirates Medical Journal

Editor-in-Chief

ISSN (Print): -
ISSN (Online): 0250-6882

Perspective Article

Tele-Oncology: An Emerging Technology in Developing Countries during the COVID-19 Pandemic

Author(s): Atlal M. Abusanad and Humaid O. Al-Shamsi*

Volume 2 , Issue 1 , 2021

Published on: 09 November, 2020

Page: [13 - 15] Pages: 3

DOI: 10.2174/0250688201999201109160857

open access plus

[2]
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[3]
Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in wuhan, China. JAMA Oncol 2020; 6(7): 1108-0.
[4]
Blumenthal SJ, Kagen J. MSJAMA. The effects of socioeconomic status on health in rural and urban America. JAMA 2002; 287(1): 109.
[http://dx.doi.org/10.1001/jama.287.1.109-JMS0102-3-1] [PMID: 11754719]
[5]
Hazin R, Qaddoumi I. Teleoncology: Current and future applications for improving cancer care globally. Lancet Oncol 2010; 11(2): 204-10.
[http://dx.doi.org/10.1016/S1470-2045(09)70288-8] [PMID: 20152772]
[7]
Measuring overall health system performance for 191 countries https://www.who.int/healthinfo/paper30.pdf
[8]
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941-53.
[http://dx.doi.org/10.1002/ijc.31937] [PMID: 30350310]
[9]
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; 323(18): 1775-6.
[http://dx.doi.org/10.1001/jama.2020.4683] [PMID: 32203977]
[10]
Doyle-Lindrud S. Telemedicine in oncology. Clin J Oncol Nurs 2016; 20(1): 27-8.
[http://dx.doi.org/10.1188/16.CJON.27-28] [PMID: 26800402]
[11]
Worster B, Swartz K. Telemedicine and palliative care: An increasing role in supportive oncology. Curr Oncol Rep 2017; 19(6): 37.
[http://dx.doi.org/10.1007/s11912-017-0600-y] [PMID: 28417310]
[12]
Raffenaud A, Gurupur V, Fernandes SL, Yeung T. Utilizing telemedicine in oncology settings: Patient favourability rates and perceptions of use analysis using Chi-Square and neural networks. Technol Health Care 2019; 27(2): 115-27.
[http://dx.doi.org/10.3233/THC-181293] [PMID: 30664510]
[13]
Albarrak AI, Mohammed R, Almarshoud N, et al. Assessment of physician’s knowledge, perception and willingness of telemedicine in Riyadh region, Saudi Arabia. J Infect Public Health 2019; S1876-0341(19): 30139-X.
[http://dx.doi.org/10.1016/j.jiph.2019.04.006] [PMID: 31060975]
[14]
Jivesh J. Sharma, Gary Gross, and Poonam Sharma. Extending oncology clinical services to rural areas of texas via teleoncology. J Oncol Pract 2012; 8(2): 68-8.
[http://dx.doi.org/10.1200/JOP.2011.000436]
[15]
Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol 2020; 31(5): 553-5.
[http://dx.doi.org/10.1016/j.annonc.2020.03.286] [PMID: 32201224]
[16]
Majeed Ammara, Lakhani Midhat, Ashraf Afia, et al. Teleoncology: Prospects and challenges for cost effective cancer care. J Clin Oncol 2019; 37(15_suppl): e23182-2.
[18]
Alaboudi A, Atkins A, Sharp B, Balkhair A, Alzahrani M, Sunbul T. Barriers and challenges in adopting Saudi telemedicine network: The perceptions of decision makers of healthcare facilities in Saudi Arabia. J Infect Public Health 2016; 9(6): 725-33.
[http://dx.doi.org/10.1016/j.jiph.2016.09.001] [PMID: 27649882]
[19]
Shachar C, Engel J, Elwyn G. Implications for telehealth in a postpandemic future: Regulatory and privacy issues. JAMA 2020; 323(23): 2375-6.
[http://dx.doi.org/10.1001/jama.2020.7943] [PMID: 32421170]

© 2022 Bentham Science Publishers | Privacy Policy